- Home
- ACCD
ACCD
Accolade Inc.
as 12-24-2024 4:00pm EST
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | PLYMOUTH MEETING |
| Market Cap: | 281.1M | IPO Year: | 2020 |
| Target Price: | $8.96 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.04 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.08 - $15.36 | Next Earning Date: | 01-09-2025 |
| Revenue: | $441,028,000 | Revenue Growth: | 16.04% |
| Revenue Growth (this year): | 14.58% | Revenue Growth (next year): | 12.65% |
Stock Insider Trading Activity of Accolade Inc. (ACCD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SINGH RAJEEV | ACCD | Chief Executive Officer | Dec 16 '24 | Sell | $3.43 | 381 | $1,307.59 | 815,851 | |
| Barnes Stephen H. | ACCD | Chief Financial Officer | Dec 16 '24 | Sell | $3.43 | 123 | $422.14 | 220,463 | |
| Cavanaugh Robert N | ACCD | President | Dec 10 '24 | Sell | $3.62 | 214 | $775.11 | 212,941 | |
| Cavanaugh Robert N | ACCD | President | Dec 2 '24 | Sell | $3.60 | 5,582 | $20,067.29 | 212,941 | |
| SINGH RAJEEV | ACCD | Chief Executive Officer | Dec 2 '24 | Sell | $3.60 | 13,357 | $48,018.42 | 815,851 | |
| Eskew Richard | ACCD | EVP General Counsel | Dec 2 '24 | Sell | $3.60 | 3,581 | $12,873.70 | 62,507 | |
| McHugh Colin | ACCD | Chief Accounting Officer | Dec 2 '24 | Sell | $3.60 | 2,388 | $8,584.86 | 61,056 | |
| Barnes Stephen H. | ACCD | Chief Financial Officer | Dec 2 '24 | Sell | $3.60 | 5,640 | $20,275.80 | 220,463 | |
| Cavanaugh Robert N | ACCD | President | Nov 18 '24 | Sell | $3.35 | 154 | $515.13 | 212,941 | |
| SINGH RAJEEV | ACCD | Chief Executive Officer | Nov 18 '24 | Sell | $3.35 | 380 | $1,271.10 | 815,851 |
Latest Accolade Inc. News
ACCD Breaking Stock News: Dive into ACCD Ticker-Specific Updates for Smart Investing
MT Newswires
8 days ago
Morgan Stanley Adjusts Price Target on Accolade to $5 From $6
GlobeNewswire
9 days ago
Accolade to Announce Fiscal Third Quarter 2025 Financial Results
Zacks
22 days ago
Accolade (ACCD) Upgraded to Buy: Here's Why
Simply Wall St.
a month ago
Accolade And 2 Other US Penny Stocks With Growth Potential
GlobeNewswire
a month ago
Accolade To Present at Upcoming Investor Conferences
Simply Wall St.
2 months ago
Accolade And 2 Other Penny Stocks To Watch On US Exchanges
Zacks
2 months ago
Accolade (ACCD) Loses -15.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PR Newswire
2 months ago
Accolade Welcomes Renalogic to Trusted Partner Ecosystem
Compare ACCD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACCD Accolade Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.